Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Dementia01:30

Dementia

486
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
486
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

745
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
745
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

512
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
512
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Dual-Light-Responsive Fe-Doped Covalent Organic Framework-Functionalized SiO<sub>2</sub> Nanofibrous Membrane for Synergistic Photothermal and Photodynamic Inactivation of Multidrug-Resistant Bacteria.

Pharmaceutics·2026
Same author

From Single-Ion to Integrated Multi-Ion Platforms: Wearable Sweat Sensors for Electrolyte Monitoring.

Biosensors·2026
Same author

Visible-Light-Driven Photoredox-Catalyzed [4 + 2] Annulation of Unsaturated α-Bromocarbonyls with α-Substituted Styrenes.

The Journal of organic chemistry·2026
Same author

Molecular mechanism of MAFB transcriptional activation of PPARD in regulating adipose browning and protecting against vascular endothelial cell injury.

Experimental cell research·2026
Same author

Insights into the function and structure of the R2TP (RUVBL1-RUVBL2-RPAP3-PIH1D1)chaperone complex.

Cell stress & chaperones·2026
Same author

The m6A demethylase FTO suppresses perivascular adipose tissue browning and exacerbates vascular injury via m6A-mediated destabilization of Irx3 mRNA and the IRX3/UCP1 axis.

Atherosclerosis·2026
Same journal

Thymidylate synthase inhibitory drugs induce p53-dependent pathways differently.

PloS one·2026
Same journal

Top-down and bottom-up attention for joint pattern classification and reconstruction.

PloS one·2026
Same journal

Short- and long-term scaling behavior of blood pressure and pulse arrival time during sleep in healthy controls and patients with obstructive sleep apnea.

PloS one·2026
Same journal

Double DQN-based secrecy energy efficiency and fairness performance in IRS-assisted NOMA systems with friendly jamming.

PloS one·2026
Same journal

10 recommendations for strengthening citizen science for improved societal and ecological outcomes: A co-produced analysis of challenges and opportunities in the 21st century.

PloS one·2026
Same journal

Paying in public: Peer effects, impression management, and willingness to pay on digital payment platforms.

PloS one·2026
関連記事をすべて見る

関連する実験動画

Updated: Jan 8, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.9K

高齢者の認知機能障害のリスク予測モデルにおける機械学習

Lei Zhang1, Xuan Xiang1, Wei Chen1

  • 1Department of Geriatrics, First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.

PloS one
|December 19, 2025
PubMed
まとめ
この要約は機械生成です。

機械学習モデルは、高齢者の認知機能障害を予測できる。年齢、人種、教育、糖尿病、うつ病などの要因を考慮したランダムフォレストモデルは、早期リスク評価において最も優れた性能を示した。

キーワード:
機械学習認知機能障害高齢者リスク予測ランダムフォレスト

さらに関連する動画

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.5K
Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

3.6K

関連する実験動画

Last Updated: Jan 8, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.9K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.5K
Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

3.6K

科学分野:

  • 老年医学
  • 医療情報学
  • 計算生物学

背景:

  • 世界的な高齢化により、高齢者の認知機能障害の有病率が増加しています。
  • 認知機能障害の早期介入は、疾患の負担とコストを削減します。
  • 早期介入のためには、正確なリスク評価ツールが必要です。

研究 の 目的:

  • 機械学習（ML）ベースの高齢者認知機能障害のリスク予測モデルを開発する。
  • MLアルゴリズムを使用して、認知機能障害の主要な予測因子を特定する。
  • 効果的なリスク評価のための医療専門家および患者向けのツールを提供する。

主な方法:

  • 1,325人の高齢者を対象に認知機能評価と血液検査を実施しました。
  • 単変量解析、ロジスティック回帰、LASSO、Borutaアルゴリズムを使用して危険因子を特定しました。
  • 9つのMLモデルを構築および評価し、SHAPを使用して解釈しました。

主要な成果:

  • SHAP分析により特定された主要な予測因子には、年齢、人種、教育、糖尿病、うつ病が含まれます。
  • モデルのキャリブレーションとデシジョンカーブは、強力な予測精度と臨床的有用性を確認しました。
  • ランダムフォレスト（RF）モデルは、最高の予測性能（AUC）を達成しました。

結論:

  • 年齢、人種、教育、糖尿病、うつ病は、認知機能障害の有意な危険因子です。
  • 評価されたMLアルゴリズムの中で、ランダムフォレストモデルは優れた予測能力を示しました。
  • 開発されたモデルは、認知機能障害の早期特定と管理のための有望なツールを提供します。